Tenderwize
Back to tender search

Open house drug discount agreements Formoterol and Fluticason, ATC R03AK11

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 201 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Fluticason, ATC R03AK11

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No indication of expected volume or historical spend; revenue may be low or zero.

Open-house agreements automatically terminate if a competitive discount contract (nationwide or regional) for the same...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount agreements for pharmaceutical products containing Formoterol and Fluticason (ATC R03AK11)
  • Contracting with all eligible pharmaceutical companies on identical terms
Show full summary

This is an open-house model (not a public procurement procedure) by AOK Bayern for non-exclusive drug discount agreements on Formoterol and Fluticason (ATC R03AK11). All eligible pharmaceutical companies can join by submitting a signed contract, annex, and declaration of reliability. Contracts run from May 2025 to April 2027, with enrollment possible until March 5, 2027. No estimated value, award criteria, or competitive selection is involved.

Risks

No indication of expected volume or historical spend; revenue may be low or zero.

Open-house agreements automatically terminate if a competitive discount contract (nationwide or regional) for the same...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company

Certifications

  • Documents in German or with certified translation

Administrative

  • Submit signed contract, annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria (open-house model)

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Formoterol and Fluticason, ATC R03AK11

Non-exclusive discount agreements for pharmaceutical products containing Formoterol and Fluticason. All eligible pharma companies can join. Contract period: 2025-05-01 to 2027-04-30. Latest enrolment: 2027-03-05.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Award Criteria

No award criteria (open-house model)

Deadline

Deadline Mar 05, 2027

Procurement Details

Publication date
18 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
176919-2025

Documents (2)

Similar tenders